Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-29

Clinical Trial Update: Treatment of Cushing's Disease With R-roscovitine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating R-roscovitine for Cushing's disease has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • R-roscovitine (roscovitine)

Snippet

Sponsor: Shlomo Melmed, MD | Conditions: Cushings Disease | Phase 2 | Status: TERMINATED | Results posted: 2021-10-29